Prognostic Evaluation of Stage B Colon Cancer Patients is Improved by an Adequate Lymphadenectomy: Results of a Secondary Analysis of a Large Scale Adjuvant Trial

ObjectiveTo determine if the extent of lymphadenectomy (number of recovered lymph nodes) was associated with long-term outcome in patients operated on for stage B and C colon cancer. Summary Background DataLymphatic spreading is the main prognostic indicator in colon cancer patients, although the optimal extent of lymphadenectomy and its prognostic impact are still unknown. MethodsIn 3,648 patients (median follow-up 3.6 years) enrolled in two consecutive INTACC multicentric trials on adjuvant therapy for colon cancer, we studied the association of the number of recovered nodes with overall survival and relapse free survival by means of univariate and Cox regression analysis. ResultsThe worst overall survival was related to ages > 65 (risk ratio [RR] = 1.30), higher grading (RR = 1.96). Better overall survival was related to female gender (RR = 0.80) and to higher number of recovered nodes (8–12 nodes, RR = 0.46, 13–17 nodes, RR = 0.76, nodes >/= 18, RR = 0.79). The same pattern was observed for relapse free survival.Longer overall and relapse free survival were related to a higher number of recovered nodes with P = .034 and P = .003 respectively (stratified analysis for absence or presence of positive nodes).Stage B patients with fewer than 7 nodes in the specimen had both shorter overall survival (P = .0000) and relapse free survival (P = .0016) than the other B patients. Outcome of stage C patients was not related to the number of recovered nodes (P = .28 and 0.12 respectively). The interaction test between stage of disease and number of recovered nodes was statistically significant (P = .017). ConclusionsStage B patients with a small number of examined nodes may be understaged. Thus, these patients might be considered for adjuvant therapy because of their poorer life expectancy than other stage B patients. For stage C patients, the number of recovered nodes does not seem to affect long-term outcome.

[1]  A. Carlin,et al.  Guidelines 2000 for colon and rectal cancer surgery. , 2001, Journal of the National Cancer Institute.

[2]  T. Namiki,et al.  Number of nodes examined and staging accuracy in colorectal carcinoma. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  F. Bosman,et al.  For patients with dukes' B (TNM stage II) colorectal carcinoma, examination of six or fewer lymph nodes is Related to poor prognosis , 1998, Cancer.

[4]  L. Layfield,et al.  Lymph node recovery from colorectal resection specimens removed for adenocarcinoma. Trends over time and a recommendation for a minimum number of lymph nodes to be recovered. , 1996, American journal of clinical pathology.

[5]  M. Gómez‐Fleitas,et al.  Colorectal adenocarcinoma: Quality of the assessment of lymph node metastases , 1994, Diseases of the colon and rectum.

[6]  Kanako Ban,et al.  Prognostic significance of location of lymph node metastases in colorectal cancer , 1992, Diseases of the colon and rectum.

[7]  J. Jass,et al.  Clinicopathological staging for colorectal cancer: An International Documentation System (IDS) and an International Comprehensive Anatomical Terminology (ICAT) , 1991, Journal of gastroenterology and hepatology.

[8]  R. Grace,et al.  Detection of lymph node metastases in colorectal carcinoma before and after fat clearance , 1989, The British journal of surgery.

[9]  O. Dent,et al.  A multivariate analysis of clinical and pathological variables in prognosis after resection of large bowel cancer , 1985, The British journal of surgery.

[10]  F. A. Coller,et al.  THE PROGNOSTIC SIGNIFICANCE OF DIRECT EXTENSION OF CARCINOMA OF THE COLON AND RECTUM , 1954, Annals of surgery.

[11]  C. Dukes,et al.  The classification of cancer of the rectum , 1980 .